Formation and antimicrobial activity of complexes of beta-cyclodextrin and some antimycotic imidazole derivatives.
Complex formation between beta-cyclodextrin and six antimycotic imidazole derivatives has been studied. The solubility of all drugs was increased in the presence of beta-cyclodextrin. The smallest increase (approx. 5-fold) was observed for miconazol, and the largest increase (approx. 160-fold) was observed for bifonazol. Apparent 1:1-complex constants were measured and found to decrease in the order: bifonazol greater than ketoconazol greater than tioconazol greater than miconazol greater than itraconazol greater than clotrimazol. The complexes appeared to possess a low, if any, antimicrobial activity. Measurement of inhibition zone sizes, with four test organisms was used to study the release of the antimycotic drugs from topical preparations. The antimycotic drugs were more readily released from topical preparations containing beta-cyclodextrin than from the same vehicles without beta-cyclodextrin. The rationale of beta-cyclodextrin addition to antimycotic topical preparations is discussed.
Van Doorne
H
H
Department of Pharmaceutical Technology, State University of Groningen, The Netherlands.
Bosch
E H
EH
Lerk
C F
CF
D000890:Anti-Infective Agents / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D003505:Cyclodextrins / Q000494:pharmacology*; D003912:Dextrins / Q000494:pharmacology*; D004347:Drug Interactions; D005782:Gels; D007093:Imidazoles / Q000494:pharmacology*; D012995:Solubility; D013213:Starch / Q000494:pharmacology*; D047392:beta-Cyclodextrins
D000890:Anti-Infective Agents; D000935:Antifungal Agents; D003505:Cyclodextrins; D003912:Dextrins; D005782:Gels; D007093:Imidazoles; D047392:beta-Cyclodextrins; D013213:Starch; C031215:betadex